AVBP R&D Expenses

Arrivent Biopharma Inc · R&D Expenses

AVBP logo

AVBP R&D Expenses

Latest reported$144.30M
AVBP R&D Expenses ($6.43M → $144.30M)
High-resolution chart · PNG

AVBP r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Arrivent Biopharma Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
153,351,000
79,004,000
64,884,000
30,433,000
6,434,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.